膳食脂肪摄入与肺癌风险:一项汇总分析
该汇总分析纳入美国、欧洲和亚洲10项前瞻性队列研究,共1,445,850名参与者、18,822例肺癌新发病例,平均随访9.4年。结果显示总脂肪和饱和脂肪摄入最高五分位与肺癌风险升高相关,多不饱和脂肪摄入最高五分位与风险降低相关,单不饱和脂肪无关联。作者认为用多不饱和脂肪替代饱和脂肪可能降低肺癌风险,尤其在吸烟者及鳞状细胞癌和小细胞癌中。
要点
- 总脂肪和饱和脂肪摄入最高五分位与肺癌风险升高相关,趋势P均<.001。
- 饱和脂肪的关联在当前吸烟者中更明显,且鳞癌和小细胞癌风险更高。
- 多不饱和脂肪摄入最高五分位与肺癌风险降低相关,单不饱和脂肪无关联。
核心结论
- 该大型国际队列联盟的发现提示,改变膳食脂肪摄入(即用多不饱和脂肪替代饱和脂肪)可能降低肺癌风险,尤其在吸烟者以及鳞状细胞癌和小细胞癌中。
研究设计与样本
- 本研究为对来自美国、欧洲和亚洲的10项前瞻性队列研究进行的汇总分析,共纳入1,445,850名参与者,平均随访9.4年,识别出18,822例肺癌新发病例。
- 各队列采用Cox回归估计风险比(HR)和95%CI,研究特异性风险估计通过随机效应或固定效应Meta分析进行合并,并排除随访前2年以处理临床前膳食变化的潜在影响。
主要发现
- 总脂肪和饱和脂肪高摄入与肺癌风险升高相关(最高五分位对比最低五分位:HR分别为1.07和1.14;95%CI分别为1.00至1.15和1.07至1.22;趋势P均<.001)。
- 饱和脂肪的正关联在当前吸烟者中比既往吸烟者或从不吸烟者更明显(HR 1.23;95%CI 1.13至1.35;趋势P<.001;交互作用P=.004)。
- 饱和脂肪与鳞状细胞癌和小细胞癌的关联比其他组织学类型更强(HR分别为1.61和1.40;95%CI分别为1.38至1.88和1.17至1.67;趋势P均<.001;异质性P<.001)。
- 多不饱和脂肪高摄入与肺癌风险降低相关(最高五分位对比最低五分位:HR 0.92;95%CI 0.87至0.98;趋势P=.02)。
- 用多不饱和脂肪替代5%能量的饱和脂肪与小细胞癌和鳞状细胞癌风险降低16%至17%相关;单不饱和脂肪未发现关联。
关键数值与推荐
- 总脂肪最高五分位对比最低五分位:HR 1.07(95%CI 1.00至1.15),趋势P<.001。
- 饱和脂肪最高五分位对比最低五分位:HR 1.14(95%CI 1.07至1.22),趋势P<.001。
- 当前吸烟者中饱和脂肪最高五分位对比最低五分位:HR 1.23(95%CI 1.13至1.35),趋势P<.001;与既往吸烟者或从不吸烟者的交互作用P=.004。
- 鳞状细胞癌中饱和脂肪最高五分位对比最低五分位:HR 1.61(95%CI 1.38至1.88);小细胞癌:HR 1.40(95%CI 1.17至1.67);趋势P均<.001;组织学类型间异质性P<.001。
- 多不饱和脂肪最高五分位对比最低五分位:HR 0.92(95%CI 0.87至0.98),趋势P=.02。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose Dietary fat may play a role in lung carcinogenesis. Findings from epidemiologic studies, however, remain inconsistent. In this pooled analysis of 10 prospective cohort studies from the United States, Europe, and Asia, we evaluated the associations of total and specific types of dietary fat with lung cancer risk. Methods Cox regression was used to estimate hazard ratios (HRs) and 95% CIs in each cohort. Study-specific risk estimates were pooled by random- or fixed-effects meta-analysis. The first 2 years of follow-up were excluded to address potential influence of preclinical dietary changes. Results Among 1,445,850 participants, 18,822 incident cases were identified (mean follow-up, 9.4 years). High intakes of total and saturated fat were associated with an increased risk of lung cancer (for highest v lowest quintile: HR, 1.07 and 1.14, respectively; 95% CI, 1.00 to 1.15 and 1.07 to 1.22, respectively; P for trend for both < .001). The positive association of saturated fat was more evident among current smokers (HR, 1.23; 95% CI, 1.13 to 1.35; P for trend < .001) than former/never smokers ( P for interaction = .004), and for squamous cell and small cell carcinoma (HR, 1.61 and 1.40, respectively; 95% CI, 1.38 to 1.88 and 1.17 to 1.67, respectively; P for trend for both < .001) than other histologic types ( P for heterogeneity < .001). In contrast, a high intake of polyunsaturated fat was associated with a decreased risk of lung cancer (HR, 0.92; 95% CI, 0.87 to 0.98 for highest v lowest quintile; P for trend = .02). A 5% energy substitution of saturated fat with polyunsaturated fat was associated with a 16% to 17% lower risk of small cell and squamous cell carcinoma. No associations were found for monounsaturated fat. Conclusion Findings from this large, international cohort consortium suggest that modifying dietary fat intake (ie, replacing saturated fat with polyunsaturated fat) may reduce lung cancer risk, particularly among smokers and for squamous cell and small cell carcinoma.
引用
- Yang JJ, Yu D, Takata Y, et al. Dietary Fat Intake and Lung Cancer Risk: A Pooled Analysis. J Clin Oncol. 2017. PMID: 28742456. doi:10.1200/JCO.2017.73.3329
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。